Dasmanthie de Silva

Dasmanthie De Silva has extensive work experience in various research roles. They started their career as a Graduate Student at the University of Miami, Miller School of Medicine in 2010. In this role, they conducted research on DEAD box RNA helicases and identified their role as mitochondrial ribosome assembly factors. They published three first author papers and mentored two undergraduate students.

In 2016, Dasmanthie De Silva joined the University of California, Berkeley as a Postdoctoral Researcher. Here, they independently led a project on the role of Eukaryotic translation initiation factor 3 (eIF3) during T cell activation. They utilized PAR-CLIP and high throughput sequencing techniques for their research and engineered an anti-CD19 CAR-T cell with improved tumor cell killing capacity. They published a first author paper and made multiple presentations and conference attendances.

Currently, Dasmanthie De Silva is a Senior Scientist I at ArsenalBio, starting in 2022.

Dasmanthie De Silva completed their Bachelor's degree in Biochemistry and Molecular Biology from the University of Peradeniya. Dasmanthie then pursued a Master of Science (MS) in Biology from the University of Miami. Later, they attended the University of Miami Miller School of Medicine where they obtained a Doctor of Philosophy (PhD) degree in Biochemistry and Molecular Biology. Subsequently, they joined the University of California, Berkeley as a postdoctoral researcher, starting in 2016 and continuing until 2022. The field of study for their postdoctoral research is not specified.